Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roopa Ramamoorthi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal for Parasitology. Drugs and Drug Resistance|December 18, 2014
WIPO Re:Search: Accelerating anthelmintic development through cross-sector partnershipsRoopa Ramamoorthi, Katy M Graef, Jennifer Dent
Future Medicinal Chemistry|May 22, 2015
Repurposing pharma assets: an accelerated mechanism for strengthening the schistosomiasis drug development pipelineRoopa Ramamoorthi, Katy M Graef, Jennifer Dent
ACS Omega|August 18, 2025
Exploration of a Class of Aryl Imidazolyl Ureas As Potent Acid Ceramidase Inhibitors for the Treatment of Fibrotic DiseasesRichard Beresis, Vijaya Prathigudupu, Carson Cable, et al.
Hepatology (Baltimore, Md.)|September 25, 2004
Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in ratsChristopher J Parsons, Blair U Bradford, Clark Q Pan, et al.
International Journal for Parasitology. Drugs and Drug Resistance|November 14, 2022
Fighting Plasmodium chloroquine resistance with acetylenic chloroquine analoguesWilian A Cortopassi, Emma Gunderson, Yasmin Annunciato, et al.
Science Translational Medicine|August 27, 2025
Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradationSachin Sharma, Vijaya Prathigudupu, Carson Cable, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal for Parasitology. Drugs and Drug Resistance|December 18, 2014
WIPO Re:Search: Accelerating anthelmintic development through cross-sector partnershipsRoopa Ramamoorthi, Katy M Graef, Jennifer Dent
Future Medicinal Chemistry|May 22, 2015
Repurposing pharma assets: an accelerated mechanism for strengthening the schistosomiasis drug development pipelineRoopa Ramamoorthi, Katy M Graef, Jennifer Dent
ACS Omega|August 18, 2025
Exploration of a Class of Aryl Imidazolyl Ureas As Potent Acid Ceramidase Inhibitors for the Treatment of Fibrotic DiseasesRichard Beresis, Vijaya Prathigudupu, Carson Cable, et al.
Hepatology (Baltimore, Md.)|September 25, 2004
Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in ratsChristopher J Parsons, Blair U Bradford, Clark Q Pan, et al.
International Journal for Parasitology. Drugs and Drug Resistance|November 14, 2022
Fighting Plasmodium chloroquine resistance with acetylenic chloroquine analoguesWilian A Cortopassi, Emma Gunderson, Yasmin Annunciato, et al.
Science Translational Medicine|August 27, 2025
Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradationSachin Sharma, Vijaya Prathigudupu, Carson Cable, et al.
Pageof 1